Rethinking How We Track and Treat Cancer

diagnostic, genomics, breast cancer, antibody drug conjugate, ADC, breast cancer, lung cancer, biomarker

HER2, HER3, and MRD: Drs. Previs and Green break down ASCO highlights and what they mean for the future of cancer diagnostics.

Jul 13^th • 19 mins listen

Why Comprehensive Testing Matters - Ken Schlosser’s Lung Cancer Story

diagnostic, biomarker, lung cancer, advocacy, precision

Biomarker testing helped Ken Schlosser live with stage IV lung cancer for over 6 years. Here's how it shaped his care plan from the start.

Jul 31^st • 23 mins listen